These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 10573186

  • 1. Potent antinociceptive effects of TRK-820, a novel kappa-opioid receptor agonist.
    Endoh T, Matsuura H, Tajima A, Izumimoto N, Tajima C, Suzuki T, Saitoh A, Suzuki T, Narita M, Tseng L, Nagase H.
    Life Sci; 1999; 65(16):1685-94. PubMed ID: 10573186
    [Abstract] [Full Text] [Related]

  • 2. TRK-820, a selective kappa-opioid agonist, produces potent antinociception in cynomolgus monkeys.
    Endoh T, Tajima A, Izumimoto N, Suzuki T, Saitoh A, Suzuki T, Narita M, Kamei J, Tseng LF, Mizoguchi H, Nagase H.
    Jpn J Pharmacol; 2001 Mar; 85(3):282-90. PubMed ID: 11325021
    [Abstract] [Full Text] [Related]

  • 3. Effect of repeated administration of TRK-820, a kappa-opioid receptor agonist, on tolerance to its antinociceptive and sedative actions.
    Suzuki T, Izumimoto N, Takezawa Y, Fujimura M, Togashi Y, Nagase H, Tanaka T, Endoh T.
    Brain Res; 2004 Jan 09; 995(2):167-75. PubMed ID: 14672806
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological characterization of ATPM [(-)-3-aminothiazolo[5,4-b]-N-cyclopropylmethylmorphinan hydrochloride], a novel mixed kappa-agonist and mu-agonist/-antagonist that attenuates morphine antinociceptive tolerance and heroin self-administration behavior.
    Wang YJ, Tao YM, Li FY, Wang YH, Xu XJ, Chen J, Cao YL, Chi ZQ, Neumeyer JL, Zhang A, Liu JG.
    J Pharmacol Exp Ther; 2009 Apr 09; 329(1):306-13. PubMed ID: 19136637
    [Abstract] [Full Text] [Related]

  • 5. Characterization of the antinociceptive effects of TRK-820 in the rat.
    Endoh T, Tajima A, Suzuki T, Kamei J, Narita M, Tseng L, Nagase H.
    Eur J Pharmacol; 2000 Jan 10; 387(2):133-40. PubMed ID: 10650153
    [Abstract] [Full Text] [Related]

  • 6. Blockade of mu-opioid receptor-mediated G-protein activation and antinociception by TRK-820 in mice.
    Mizoguchi H, Hung KC, Leitermann R, Narita M, Nagase H, Suzuki T, Tseng LF.
    Eur J Pharmacol; 2003 Feb 07; 461(1):35-9. PubMed ID: 12568913
    [Abstract] [Full Text] [Related]

  • 7. Effects of Intrathecal κ-Opioid Receptor Agonist on Morphine-Induced Itch and Antinociception in Mice.
    Sakakihara M, Imamachi N, Saito Y.
    Reg Anesth Pain Med; 2016 Feb 07; 41(1):69-74. PubMed ID: 26587674
    [Abstract] [Full Text] [Related]

  • 8. The novel kappa-opioid receptor agonist TRK-820 has no affect on the development of antinociceptive tolerance to morphine in mice.
    Tsuji M, Yamazaki M, Takeda H, Matsumiya T, Nagase H, Tseng LF, Narita M, Suzuki T.
    Eur J Pharmacol; 2000 Apr 07; 394(1):91-5. PubMed ID: 10771039
    [Abstract] [Full Text] [Related]

  • 9. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H, Shimoyama N, Sora I, Uhl GR, Fukuda Y, Moriya H, Shimoyama M.
    Brain Res; 2006 Apr 14; 1083(1):61-9. PubMed ID: 16530171
    [Abstract] [Full Text] [Related]

  • 10. A novel kappa-opioid receptor agonist, TRK-820, blocks the development of physical dependence on morphine in mice.
    Tsuji M, Takeda H, Matsumiya T, Nagase H, Yamazaki M, Narita M, Suzuki T.
    Life Sci; 2000 Apr 14; 66(25):PL353-8. PubMed ID: 10894094
    [Abstract] [Full Text] [Related]

  • 11. Comparison of pharmacological activities of three distinct kappa ligands (Salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo.
    Wang Y, Tang K, Inan S, Siebert D, Holzgrabe U, Lee DY, Huang P, Li JG, Cowan A, Liu-Chen LY.
    J Pharmacol Exp Ther; 2005 Jan 14; 312(1):220-30. PubMed ID: 15383632
    [Abstract] [Full Text] [Related]

  • 12. Pentazocine-induced antinociception is mediated mainly by μ-opioid receptors and compromised by κ-opioid receptors in mice.
    Shu H, Hayashida M, Arita H, Huang W, Zhang H, An K, Wu G, Hanaoka K.
    J Pharmacol Exp Ther; 2011 Aug 14; 338(2):579-87. PubMed ID: 21543510
    [Abstract] [Full Text] [Related]

  • 13. Discovery of a structurally novel opioid kappa-agonist derived from 4,5-epoxymorphinan.
    Nagase H, Hayakawa J, Kawamura K, Kawai K, Takezawa Y, Matsuura H, Tajima C, Endo T.
    Chem Pharm Bull (Tokyo); 1998 Feb 14; 46(2):366-9. PubMed ID: 9501472
    [Abstract] [Full Text] [Related]

  • 14. Antinociception by spinal and systemic oxycodone: why does the route make a difference? In vitro and in vivo studies in rats.
    Lemberg KK, Kontinen VK, Siiskonen AO, Viljakka KM, Yli-Kauhaluoma JT, Korpi ER, Kalso EA.
    Anesthesiology; 2006 Oct 14; 105(4):801-12. PubMed ID: 17006080
    [Abstract] [Full Text] [Related]

  • 15. Effect of endothelin-A receptor antagonist on mu, delta and kappa opioid receptor-mediated antinociception in mice.
    Bhalla S, Zhang Z, Patterson N, Gulati A.
    Eur J Pharmacol; 2010 Jun 10; 635(1-3):62-71. PubMed ID: 20303944
    [Abstract] [Full Text] [Related]

  • 16. Opioid antinociception in ovariectomized monkeys: comparison with antinociception in males and effects of estradiol replacement.
    Negus SS, Mello NK.
    J Pharmacol Exp Ther; 1999 Sep 10; 290(3):1132-40. PubMed ID: 10454487
    [Abstract] [Full Text] [Related]

  • 17. Suppression of acute herpetic pain-related responses by the kappa-opioid receptor agonist (-)-17-cyclopropylmethyl-3,14beta-dihydroxy-4,5alpha-epoxy-beta-[n-methyl-3-trans-3-(3-furyl) acrylamido] morphinan hydrochloride (TRK-820) in mice.
    Takasaki I, Suzuki T, Sasaki A, Nakao K, Hirakata M, Okano K, Tanaka T, Nagase H, Shiraki K, Nojima H, Kuraishi Y.
    J Pharmacol Exp Ther; 2004 Apr 10; 309(1):36-41. PubMed ID: 14711930
    [Abstract] [Full Text] [Related]

  • 18. Novel κ-opioid receptor agonist MB-1C-OH produces potent analgesia with less depression and sedation.
    Zhang LS, Wang J, Chen JC, Tao YM, Wang YH, Xu XJ, Chen J, Xu YG, Xi T, Hu XW, Wang YJ, Liu JG.
    Acta Pharmacol Sin; 2015 May 10; 36(5):565-71. PubMed ID: 25816912
    [Abstract] [Full Text] [Related]

  • 19. Effects of ibogaine and noribogaine on the antinociceptive action of mu-, delta- and kappa-opioid receptor agonists in mice.
    Bhargava HN, Cao YJ, Zhao GM.
    Brain Res; 1997 Mar 28; 752(1-2):234-8. PubMed ID: 9106462
    [Abstract] [Full Text] [Related]

  • 20. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic.
    Raffa RB, Friderichs E, Reimann W, Shank RP, Codd EE, Vaught JL.
    J Pharmacol Exp Ther; 1992 Jan 28; 260(1):275-85. PubMed ID: 1309873
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.